Skip to main content

Table 3 COVID-19 testing capacity, influenza surveillance, border control measures, and preparedness activities in the 24 countries with no reported cases as of 30 March 2020

From: Countries with delayed COVID-19 introduction – characteristics, drivers, gaps, and opportunities

Country

Testing and surveillance

Border control measures

COVID-19 preparedness activities

In-country COVID-19 testing (if yes, capacity)

Export COVID-19 testing

Flu surveillance (if yes, typea)

Travel restriction

Border closure

Entry screening

Traveler quarantine

Preparedness plan

Mass gathering restriction

School closure

Business closure

COVID-19 funding

Health worker training

PPEb

Quarantine isolation facility

AFRO

 Botswana

Yes (500/day)

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Unknown

 Burundi

Yes (Unknown)

No

Yes

Unknown

Yes

Yes

Unknown

Unknown

No

Unknown

Yes

Unknown

Yes

Yes

 Comoros

No

Unknown

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Unknown

Yes

Yes

Yes

Yes

 Lesotho

No

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

 Malawi

Yes (> 20 K total tests)

No

Yes

Unknown

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Unknown

 Sao Tome and Principe

No

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Unknown

Yes

Unknown

 Sierra Leone

Yes (35/mil people/day)

Yes (Lab,

ILI, SARI)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Unknown

Yes

 South Sudan

Yes (20 K total tests)

Yes (Lab, ILI, SARI)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

EMRO

 Yemen

Yes (Thousands)

Yes (Lab)

Yes

Yes

Yes

Yes

Yes

No

Yes

Unknown

Yes

Yes

Yes

Unknown

EURO

 Tajikistan

Yes (Unknown)

Yes (Lab, ILI, SARI)

Yes

Unknown

Unknown

Yes

Unknown

Unknown

Unknown

Unknown

Yes

Unknown

Unknown

Yes

 Turkmenistan

Yes (Unknown)

Yes (Lab, ILI, SARI)

Yes

Yes

Yes

Yes

Yes

Unknown

Unknown

Unknown

Yes

Unknown

Yes

Yes

SEARO

 North Korea

Yes (Unknown)

Yes (Lab, ILI, SARI)

Unknown

Unknown

Yes

Yes

Yes

Yes

Yes

Unknown

Unknown

Unknown

Yes

Yes

WPRO

 Cook Islands

No

Yes

Yes (ILI)

Yes

Yes

Unknown

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Unknown

 Kiribati

No

Yes

Yes (ILI)

Unknown

No

Yes

Yes

Yes

No

Yes

Unknown

Unknown

Unknown

Unknown

Unknown

 Marshall Islands

No

Yes

Yes (ILI)

Yes

Yes

Yes

Unknown

Yes

Unknown

Yes

Unknown

Yes

Yes

Yes

Yes

 Micronesia

No

Yes

Yes (ILI)

Yes

Unknown

Yes

Yes

Yes

Unknown

Unknown

Unknown

Yes

Unknown

Unknown

Yes

 Nauru

No

Yes

No

Yes

No

Yes

Yes

Yes

No

No

No

Yes

Unknown

Yes

Yes

 Niue

Unknown

Unknown

Yes (ILI)

Yes

No

Unknown

Yes

Yes

Unknown

Yes

Unknown

Yes

Unknown

Unknown

Unknown

 Palau

No

Yes

Yes (ILI)

Yes

No

Yes

Yes

Yes

Yes

Yes

Unknown

Yes

Unknown

Unknown

Unknown

 Samoa

No

Yes

Yes (ILI)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Unknown

Yes

Unknown

 Solomon Islands

No

Yes

Yes (ILI)

Yes

Yes

Unknown

Yes

Yes

Unknown

Unknown

Yes

Yes

Unknown

Yes

Yes

 Tonga

Unknown

Unknown

Yes (ILI)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Unknown

Unknown

Unknown

Unknown

 Tuvalu

Unknown

Unknown

Yes (ILI)

Yes

Unknown

Yes

Unknown

Yes

Yes

Unknown

Unknown

Unknown

Unknown

Unknown

Unknown

 Vanuatu

No

Unknown

Yes (ILI)

Yes

Yes

Unknown

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

  1. aLab laboratory confirmed influenza, ILI influenza-like illness, SARI severe acute respiratory infections
  2. bPPE personal protective equipment